Available Until 6/14/2026
View Cart

USP <795>: Impactful Changes and Other Nonsterile Compounding Best Practices

Planned in cooperation with the ASHP SICP Compounding Practice SAG

ACPE Activity Number: 0204-0000-23-563-H07-P/T
Release Date:  6/14/2023
Expiration Date: 6/14/2026 
Activity Type: Knowledge-based 
CE Credits:  1.0 contact hour, (0.10 CEUs)
Activity Fee: Member – Free / Non-Member – Not Available 

This activity is a recording from a live webinar and those that claim credit for the live webinar should not claim credit for this activity.

Activity Overview 

This webinar will cover key changes between the current USP <795> and the revised version, including strategies that compounders are using to implement these changes. Resources that you can use to implement these changes will be reviewed.   

   
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

This activity was planned to meet the educational needs of pharmacists and pharmacy technicians who are responsible for or have an interest in nonsterile and sterile compounding and hazardous drug safety. 

After completing this activity, the learner should be able to…

  • Summarize key revisions to USP Chapter <795> that will become enforceable on Nov. 1, 2023.
  • Describe considerations for implementing key changes to <795>.
  • Describe additional best practices for nonsterile compounding that are not included in USP <795>. 

  • Introduction and Announcements 

  • Presentation  

  • Questions, Answers, and Discussion 

Cindy Brasher, PharmD, MS, BCSCP
Manager of Compounding
St. Jude Children's Research Hospital
Memphis, TN 

Ashley Bowden, PharmD, MS, BCPS
Pharmacy Manager
University of Utah Health
Salt Lake City, UT 

Moderator

Rena Sackett, PharmD, BCPS
Director, Member Relations
ASHP
Bethesda, MD 

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company. 

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience. 

  • No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company. 

This activity consists of recordings of faculty slides presentations, active learning activities, discussion, and handouts. Participants must participate in the activity in its entirety to claim continuing pharmacy education credit online at ASHP Learning Center. Follow the prompts online to complete the evaluation, claim credit and view the statement of credit immediately after completing the activity. 

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.